BioAge Labs Inc
BioAge Labs Inc (BIOA) Option Chain
Read more
Tracking the BIOA option chain helps you see every strike and expiry on BioAge Labs Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BIOA options activity at a glance. Use our scanner to monitor the BIOA option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BIOA stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where BIOA options are being actively traded, and where they are not.
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 15.62 | 0 | 0 | 0.53 | 2.72 | 1.00 | 5.50 | 2.50 | -54.95 | — | 0.05 | 0.00 | 0.05 | 0 | 0 | 84.38 |
| 55.20 | 1,273 | 0 | 0.98 | 0.22 | — | 1.20 | 5.00 | -9.91 | — | 0.75 | 0.00 | 0.75 | 0 | 1,737 | 44.80 |
| 78.76 | 216 | 0 | 4.90 | 0.00 | — | 4.90 | 7.50 | +35.14 | 0.10 | 4.90 | 2.28 | 0.22 | 0 | 1 | 21.24 |
| 89.82 | 10 | 0 | 4.90 | 0.00 | — | 4.90 | 10.00 | +80.18 | 2.05 | 6.40 | 4.78 | -0.56 | 1 | 1 | 10.18 |
| 94.94 | 0 | 0 | 4.90 | 0.00 | — | 4.90 | 12.50 | +125.23 | 4.50 | 9.00 | 7.28 | -0.53 | 0 | 0 | 5.06 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV Rank100.00% High
- Market cap (M$)255
- 52 weeks high-78.62%
- 52 weeks low15.38%
- Analyst recommendationBuy
1.60 - Target price$28.56
447.13% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-2.55
- EPS growth next 5 years-4.97%
As of Nov 13, 2026